Sarepta Therapeutics note 1.500% 11/1 shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Sarepta Therapeutics note 1.500% 11/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics note 1.500% 11/1 held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Capstone Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $9.1M | 5.1M | 1.79 |
| 2023-12-31 | $7.2M | 5.1M | 1.42 |
| 2023-09-30 | $9.0M | 5.1M | 1.77 |
| 2023-06-30 | $8.6M | 5.1M | 1.69 |
| 2023-03-31 | $14M | 7.1M | 1.93 |
| 2022-06-30 | $18M | 15M | 1.26 |
| 2022-03-31 | $19M | 15M | 1.31 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors
Top funds holding Sarepta Therapeutics note 1.500% 11/1
View all funds holding Sarepta Therapeutics note 1.500% 11/1